Affinity Asset Advisors’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Affinity Asset Advisors's IBRX Position: Q3 2026 in Review
Affinity Asset Advisors opened a new position in ImmunityBio (IBRX) in Q3 2026: 1,180,000 shares worth $11.1M. The stake represents 0.45% of the portfolio and ranks #50 among its holdings.
405 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Affinity Asset Advisors held 1,180,000 shares of ImmunityBio worth $11.1M as of Q3 2026.
- ImmunityBio was a new Affinity Asset Advisors position in Q3 2026.
- ImmunityBio made up 0.45% of Affinity Asset Advisors's portfolio in Q3 2026, its #50 holding.
- 405 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Affinity Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.